Dr. Gerrit Niehoff

Represents a Taiwanese pharmaceutical company in an ICC arbitration regarding the licensing of a drug and regulatory issues of marketing authorizations in Europe and the US (amount in dispute EUR 400 million).

Represents a global biotech company in preparation of a potential arbitration arising from a supply agreement in connection with minimum purchase volumes (amount in dispute > EUR 50 million).

Represents a European lighting company in an international litigation arising out of a cross-license agreement (amount in dispute > EUR 8 million).

Reached a favorable settlement for a Swiss R&D company in various related IP litigations regarding patent infringement and damages resulting from this infringement against German competitor (amount in dispute > EUR 50 million).

Reached a favorable settlement for a global pharmaceutical company in an ICC arbitration seated in Tokyo regarding damages for breach of a license agreement (amount in dispute > USD 20 million).

Represented a German power plant owner in an ICC arbitration about the breach of various performance guarantees (amount in dispute > EUR 140 million).

Reached a favorable settlement for an international plant manufacturer in a dispute with its Russian customer about the building of a chemical plant.

Advised a multinational manufacturer of technical gases in preparation of a potential arbitration with the manufacturer of defective compressors (amount in dispute > EUR 1 million).